Provided by Tiger Fintech (Singapore) Pte. Ltd.

HCW Biologics Inc.

4.57
-0.2900-5.97%
Pre-market: 4.570.00000.00%08:01 EDT
Volume:45.38K
Turnover:217.78K
Market Cap:9.50M
PE:-0.15
High:5.15
Open:4.81
Low:4.50
Close:4.86
Loading ...
Nov 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 28, 2021

Major Issues Report

8-K - Current report
Oct 27, 2021

Major Issues Report

8-K - Current report
Aug 13, 2021

Major Issues Report

8-K - Current report
Aug 13, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 02, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jul 26, 2021

Major Issues Report

8-K - Current report
Jul 21, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jul 16, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 16, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 15, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 13, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 13, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 12, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jul 09, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jul 07, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jul 07, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jun 15, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 15, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jun 04, 2021

Correspondence

CORRESP [Cover] - Correspondence